Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
439.50    71.50 (19.43%)
Bid:
439.00
Ask:
440.00
Spread: 1.00 (0.228%)
Market Cap: £1.20b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Q3 2021 Trading Update

20 Jan 2021 07:00

RNS Number : 2179M
CMC Markets Plc
20 January 2021
Β 

20 January 2021

CMC Markets Plc

Β 

Q3 2021 Trading Update

Β 

Continued strong performance underpinned by high client income retention

CMC Markets Plc ("CMC" or the "Group"), a leading global provider of online trading and institutional ("B2B") platform technology solutions,Β today issues a trading update for the period from 1 October 2020 to 31 December 2020 ("Q3 2021" or the "period").

Β 

Trading Update

Β 

CMC's continued investment in platform technology and risk management, and its strategy of targeting high-quality premium and professional clients has continued to underpin the strong performance of the business over a sustained period of time.

Β 

In Q3 2021, the entire business has continued to perform very well, with high active client numbers resulting in strong client trading activity, although at lower levels than earlier in the financial year. In addition, client income retention remained well in excess of 80%, but below the levels reported for H1 2021, as guided.

Β 

Our investment in platform technology continues to attract and retain premium clients, with market leading functionality and robust operational performance. This was especially evident during the November Pfizer vaccine announcement when our platforms remained resilient and performed very well. The business reported no outages during this very volatile trading period.

Β 

Client acquisition levels remain high and the quality of this year's new cohort of clients remain encouraging as they continue to show similarly high value qualities to prior cohorts.

Β 

Following the continued strong performance, the Board is confident that net operating income for the Full Year 2021 will be at the upper end of the current market consensus1.

Β 

Peter Cruddas, Chief Executive Officer, commented:

Β 

"I'm delighted by our performance, and as we enter our final financial reporting quarter, we are focusing on delivering on our premium client strategy through technology, service and a resilient trading platform. In addition, we have a healthy pipeline of projects that will drive new revenue streams, which I will talk more about in the next financial year.

Β 

I am very excited about the opportunities to continue to grow and diversify this business on the back of our platform technology. I have talked a lot in the past about investment in technology and people, and this will continue to be a priority as we seek to maintain and expand our competitive advantage.

Β 

We will do this through product expansion, our technology expertise and our capability to deliver an enhanced user experience across different asset classes. We have already proven we can do this with our stockbroking business in Australia. This will further help us attract and retain high value clients.

Β 

In addition, continued investment in our risk infrastructure is delivering latency reduction and pricing and execution efficiencies. This allows us to capture a higher percentage of our premium client income especially during volatile market conditions.

Β 

As a Group, we will continue to deliver underlying growth and considerable value to shareholders, through strong results, an attractive dividend policy, investment in the business, investment in technology and investment in risk management infrastructure.

Β 

I am very positive about the outlook and strong momentum that is underpinned by my incessant desire to keep investing in the business through technology and quality staff."

Β 

Β 

Upcoming results

Β 

CMC expects to announce its full year pre-close trading update on 8 April 2021.

Forward looking statements

Β 

This trading update may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward looking statements to reflect events or developments occurring after the date such statements are published.

Β 

1 As at 19 January 2021, the company compiled Full Year 2021 consensus, including 5 of the 6 covering analysts, is as follows:

Β· Net operating income of Β£376.6 million, ranging from Β£370.2 million to Β£387.5 million

Β· Profit Before Tax of Β£197.2 million, ranging from Β£191.3 million to Β£206.3 million

Β 

Enquiries

CMC Markets Plc investor.relations@cmcmarkets.com

Euan Marshall, Chief Financial Officer

Β 

Camarco +44 (0) 20 3757 4994

Geoffrey Pelham-Lane

Ed Gascoigne-Pees

Jennifer Renwick

Β 

Notes to Editors

Β 

CMC Markets Plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The Group serves retail and institutional clients through regulated offices and branches in 12 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFZGMMVLZGMZM
Date   Source Headline
4th Jun 20267:05 amRNSDirectorate change
4th Jun 20267:00 amRNSPreliminary Results
6th May 20264:45 pmRNSDirector/PDMR Shareholding
8th Apr 20263:49 pmRNSDirector/PDMR Shareholding
24th Mar 202610:00 amRNSDirectorate change
6th Mar 20263:54 pmRNSDirector/PDMR Shareholding
6th Feb 20263:57 pmRNSDirector/PDMR Shareholding
12th Jan 202612:16 pmRNSDirector/PDMR Shareholding
6th Jan 20261:38 pmRNSDirector/PDMR Shareholding
8th Dec 20252:22 pmRNSDirector/PDMR Shareholding
20th Nov 20257:10 amRNSDividend Declaration
20th Nov 20257:00 amRNSInterim Results
6th Nov 20254:55 pmRNSDirector/PDMR Shareholding
3rd Nov 20251:30 pmRNSDirectorate change
7th Oct 20254:02 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSWestpac and CMC Extend Strategic Relationship
11th Sep 20259:40 amRNSDirector/PDMR Shareholding
8th Sep 202511:50 amRNSDirector/PDMR Shareholding
5th Sep 202512:14 pmRNSAppointment of Senior Independent Director
19th Aug 20254:22 pmRNSDirector/PDMR Shareholding
19th Aug 20254:20 pmRNSDirector/PDMR Shareholding
7th Aug 20253:59 pmRNSHolding(s) in Company
6th Aug 20254:08 pmRNSDirector/PDMR Shareholding
4th Aug 20251:23 pmRNSDirector/PDMR Shareholding
31st Jul 20253:53 pmRNSDirector/PDMR Shareholding
24th Jul 20251:21 pmRNSResult of AGM
23rd Jul 20255:20 pmRNSDirector/PDMR Shareholding
18th Jul 20252:36 pmRNSDirector/PDMR Shareholding
16th Jul 20254:57 pmRNSDirector/PDMR Shareholding
8th Jul 20253:04 pmRNSDirector/PDMR Shareholding
20th Jun 20255:11 pmRNSNotice of AGM
19th Jun 20254:53 pmRNSDirector/PDMR Shareholding
18th Jun 202512:18 pmRNSDirector/PDMR Shareholding
12th Jun 20259:45 amRNSConfirmation of Dividend Details
6th Jun 20254:07 pmRNSDirector/PDMR Shareholding
5th Jun 202512:48 pmRNSAnnual Financial Report
5th Jun 20257:30 amRNSDividend Declaration
5th Jun 20257:05 amRNSBoard and Directorate Changes
5th Jun 20257:00 amRNSFinal Results
7th May 20253:35 pmRNSDirector/PDMR Shareholding
8th Apr 20252:10 pmRNSDirector/PDMR Shareholding
7th Mar 20254:48 pmRNSDirector/PDMR Shareholding
6th Mar 202512:21 pmRNSDirector/PDMR Shareholding
27th Feb 20253:25 pmRNSDirector/PDMR Shareholding
25th Feb 20257:00 amRNSDirectorate Change
6th Feb 20253:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
13th Jan 202510:08 amRNSDirector/PDMR Shareholding
6th Jan 20254:24 pmRNSDirector/PDMR Shareholding
6th Dec 202411:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.